Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

620 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Markers of response for the antiangiogenic agent bevacizumab.
Lambrechts D, Lenz HJ, de Haas S, Carmeliet P, Scherer SJ. Lambrechts D, et al. J Clin Oncol. 2013 Mar 20;31(9):1219-30. doi: 10.1200/JCO.2012.46.2762. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401453 Review.
VEGF: a modifier of the del22q11 (DiGeorge) syndrome?
Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, Maity S, Kneer P, von der Ohe M, Swillen A, Maes C, Gewillig M, Molin DG, Hellings P, Boetel T, Haardt M, Compernolle V, Dewerchin M, Plaisance S, Vlietinck R, Emanuel B, Gittenberger-de Groot AC, Scambler P, Morrow B, Driscol DA, Moons L, Esguerra CV, Carmeliet G, Behn-Krappa A, Devriendt K, Collen D, Conway SJ, Carmeliet P. Stalmans I, et al. Among authors: lambrechts d. Nat Med. 2003 Feb;9(2):173-82. doi: 10.1038/nm819. Epub 2003 Jan 21. Nat Med. 2003. PMID: 12539040
Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.
Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M, Bono F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr-Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, Communi D, Shibuya M, Collen D, Conway EM, Carmeliet P. Autiero M, et al. Among authors: lambrechts d. Nat Med. 2003 Jul;9(7):936-43. doi: 10.1038/nm884. Nat Med. 2003. PMID: 12796773
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.
Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P. Lambrechts D, et al. Nat Genet. 2003 Aug;34(4):383-94. doi: 10.1038/ng1211. Nat Genet. 2003. PMID: 12847526 Free article.
Medicine: genetic spotlight on a blood defect.
Lambrechts D, Carmeliet P. Lambrechts D, et al. Nature. 2004 Feb 12;427(6975):592-4. doi: 10.1038/427592a. Nature. 2004. PMID: 14961101 No abstract available.
Sculpting heart valves with NFATc and VEGF.
Lambrechts D, Carmeliet P. Lambrechts D, et al. Cell. 2004 Sep 3;118(5):532-4. doi: 10.1016/j.cell.2004.08.022. Cell. 2004. PMID: 15339657 Free article. Review.
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.
Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, Robberecht W, Conway EM, Collen D, Moons L, Carmeliet P. Storkebaum E, et al. Among authors: lambrechts d. Nat Neurosci. 2005 Jan;8(1):85-92. doi: 10.1038/nn1360. Epub 2004 Nov 28. Nat Neurosci. 2005. PMID: 15568021 Free article.
620 results